0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Decentralized Clinical Trials (DCTs) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-28Z8729
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Decentralized Clinical Trials DCTs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Decentralized Clinical Trials (DCTs) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-28Z8729
Report
August 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Decentralized Clinical Trials (DCTs) Sales Market Size

The global Decentralized Clinical Trials (DCTs) market size was US$ 9384 million in 2024 and is forecast to a readjusted size of US$ 24340 million by 2031 with a CAGR of 14.8% during the forecast period 2025-2031.

Decentralized Clinical Trials (DCTs) Sales Market

Decentralized Clinical Trials (DCTs) Sales Market

The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model. Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
The decentralized clinical trials (DCT) market is driven by the growing need for patient-centric trial designs that improve accessibility and convenience. By leveraging technology such as telemedicine, wearables, and remote monitoring, DCTs allow patients to participate from their homes, reducing the burden of travel and time commitments. This not only enhances patient recruitment and retention rates but also enables trials to include more diverse and geographically dispersed populations, ultimately accelerating the drug development process. However, a significant challenge in the decentralized clinical trials market is the integration of complex digital tools and data management systems. Ensuring the seamless and secure transfer of patient data across various platforms requires significant investment in infrastructure and poses privacy concerns. Additionally, regulatory frameworks for DCTs are still evolving, and inconsistencies in approval processes across regions can create barriers for global trial implementation. Ensuring patient compliance and maintaining trial integrity in a remote setting also add layers of complexity to trial management.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%. North America is the largest sales region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
The global Decentralized Clinical Trials (DCTs) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation

Scope of Decentralized Clinical Trials (DCTs) Sales Market Report

Report Metric Details
Report Name Decentralized Clinical Trials (DCTs) Sales Market
Forecasted market size in 2031 US$ 24340 million
CAGR 14.8%
Forecasted years 2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)
By Application: (Core Demand Driver vs Emerging Opportunity)
  • Oncology
  • Cardiovascular
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health, Clinical Ink, Medable, Science 37
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Decentralized Clinical Trials (DCTs) market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Observational in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cardiovascular in India).
  • Chapter 6: Regional revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Decentralized Clinical Trials (DCTs) value chain, addressing:

FAQ for this report

What is the Decentralized Clinical Trials (DCTs) Sales Market size in 2031?

Ans: The Decentralized Clinical Trials (DCTs) Sales Market size in 2031 will be US$ 24340 million.

What is the market share of major companies in Decentralized Clinical Trials (DCTs) Sales Market?

Ans: Global top five manufacturers hold a share over 45%.

What is the Decentralized Clinical Trials (DCTs) Sales Market share by type?

Ans: In terms of product, Interventional is the largest segment, with a share over 45%.

Who are the main players in the Decentralized Clinical Trials (DCTs) Sales Market report?

Ans: The main players in the Decentralized Clinical Trials (DCTs) Sales Market are Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health, Clinical Ink, Medable, Science 37

What are the Application segmentation covered in the Decentralized Clinical Trials (DCTs) Sales Market report?

Ans: The Applications covered in the Decentralized Clinical Trials (DCTs) Sales Market report are Oncology, Cardiovascular, Others

What are the Type segmentation covered in the Decentralized Clinical Trials (DCTs) Sales Market report?

Ans: The Types covered in the Decentralized Clinical Trials (DCTs) Sales Market report are Interventional, Observational, Expanded Access

Recommended Reports

Clinical Trials Technology

Digital Therapeutics & Devices

Oncology & Specialized Therapy

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Interventional
1.2.3 Observational
1.2.4 Expanded Access
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Region (2020-2025)
2.4 Global Decentralized Clinical Trials (DCTs) Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Decentralized Clinical Trials (DCTs) Market Size and Prospective (2020-2031)
2.5.2 Europe Decentralized Clinical Trials (DCTs) Market Size and Prospective (2020-2031)
2.5.3 China Decentralized Clinical Trials (DCTs) Market Size and Prospective (2020-2031)
2.5.4 Japan Decentralized Clinical Trials (DCTs) Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2020-2025)
3.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2026-2031)
3.3 Different Types Decentralized Clinical Trials (DCTs) Representative Players
4 Breakdown Data by Application
4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2020-2025)
4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Decentralized Clinical Trials (DCTs) Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2020-2025)
5.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Decentralized Clinical Trials (DCTs) Revenue
5.4 Global Decentralized Clinical Trials (DCTs) Market Concentration Analysis
5.4.1 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trials (DCTs) Revenue in 2024
5.5 Global Key Players of Decentralized Clinical Trials (DCTs) Head office and Area Served
5.6 Global Key Players of Decentralized Clinical Trials (DCTs), Product and Application
5.7 Global Key Players of Decentralized Clinical Trials (DCTs), Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Decentralized Clinical Trials (DCTs) Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025)
6.1.2.2 North America Decentralized Clinical Trials (DCTs) Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025)
6.1.3.2 North America Decentralized Clinical Trials (DCTs) Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Decentralized Clinical Trials (DCTs) Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025)
6.2.2.2 Europe Decentralized Clinical Trials (DCTs) Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025)
6.2.3.2 Europe Decentralized Clinical Trials (DCTs) Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Decentralized Clinical Trials (DCTs) Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025)
6.3.2.2 China Decentralized Clinical Trials (DCTs) Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025)
6.3.3.2 China Decentralized Clinical Trials (DCTs) Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Decentralized Clinical Trials (DCTs) Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025)
6.4.2.2 Japan Decentralized Clinical Trials (DCTs) Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025)
6.4.3.2 Japan Decentralized Clinical Trials (DCTs) Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Medidata
7.1.1 Medidata Company Details
7.1.2 Medidata Business Overview
7.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
7.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.1.5 Medidata Recent Development
7.2 IQVIA
7.2.1 IQVIA Company Details
7.2.2 IQVIA Business Overview
7.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
7.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.2.5 IQVIA Recent Development
7.3 Labcorp
7.3.1 Labcorp Company Details
7.3.2 Labcorp Business Overview
7.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction
7.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.3.5 Labcorp Recent Development
7.4 PRA Health Sciences
7.4.1 PRA Health Sciences Company Details
7.4.2 PRA Health Sciences Business Overview
7.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
7.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.4.5 PRA Health Sciences Recent Development
7.5 Parexel
7.5.1 Parexel Company Details
7.5.2 Parexel Business Overview
7.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
7.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.5.5 Parexel Recent Development
7.6 ICON
7.6.1 ICON Company Details
7.6.2 ICON Business Overview
7.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction
7.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.6.5 ICON Recent Development
7.7 Oracle
7.7.1 Oracle Company Details
7.7.2 Oracle Business Overview
7.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
7.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.7.5 Oracle Recent Development
7.8 CRF Health
7.8.1 CRF Health Company Details
7.8.2 CRF Health Business Overview
7.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
7.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.8.5 CRF Health Recent Development
7.9 Clinical Ink
7.9.1 Clinical Ink Company Details
7.9.2 Clinical Ink Business Overview
7.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
7.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.9.5 Clinical Ink Recent Development
7.10 Medable
7.10.1 Medable Company Details
7.10.2 Medable Business Overview
7.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction
7.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.10.5 Medable Recent Development
7.11 Science 37
7.11.1 Science 37 Company Details
7.11.2 Science 37 Business Overview
7.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
7.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
7.11.5 Science 37 Recent Development
8 Decentralized Clinical Trials (DCTs) Market Dynamics
8.1 Decentralized Clinical Trials (DCTs) Industry Trends
8.2 Decentralized Clinical Trials (DCTs) Market Drivers
8.3 Decentralized Clinical Trials (DCTs) Market Challenges
8.4 Decentralized Clinical Trials (DCTs) Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Decentralized Clinical Trials (DCTs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Market Decentralized Clinical Trials (DCTs) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Decentralized Clinical Trials (DCTs) Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 5. Global Decentralized Clinical Trials (DCTs) Revenue Share by Region (2020-2025)
 Table 6. Global Decentralized Clinical Trials (DCTs) Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 7. Global Decentralized Clinical Trials (DCTs) Revenue Share Forecast by Region (2026-2031)
 Table 8. Global Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025) & (US$ Million)
 Table 9. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2020-2025)
 Table 10. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 11. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2026-2031)
 Table 12. Representative Players of Each Type
 Table 13. Global Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025) & (US$ Million)
 Table 14. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2020-2025)
 Table 15. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 16. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2026-2031)
 Table 17. New Sources of Growth in Decentralized Clinical Trials (DCTs) Application
 Table 18. Global Decentralized Clinical Trials (DCTs) Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Decentralized Clinical Trials (DCTs) Market Share by Players (2020-2025)
 Table 20. Global Top Decentralized Clinical Trials (DCTs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trials (DCTs) as of 2024)
 Table 21. Ranking of Global Top Decentralized Clinical Trials (DCTs) Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Decentralized Clinical Trials (DCTs) Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Decentralized Clinical Trials (DCTs), Headquarters and Area Served
 Table 24. Global Key Players of Decentralized Clinical Trials (DCTs), Product and Application
 Table 25. Global Key Players of Decentralized Clinical Trials (DCTs), Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. North America Decentralized Clinical Trials (DCTs) Revenue by Company (2020-2025) & (US$ Million)
 Table 28. North America Decentralized Clinical Trials (DCTs) Revenue Market Share by Company (2020-2025)
 Table 29. North America Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025) & (US$ Million)
 Table 30. North America Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Europe Decentralized Clinical Trials (DCTs) Revenue by Company (2020-2025) & (US$ Million)
 Table 32. Europe Decentralized Clinical Trials (DCTs) Revenue Market Share by Company (2020-2025)
 Table 33. Europe Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025) & (US$ Million)
 Table 34. Europe Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025) & (US$ Million)
 Table 35. China Decentralized Clinical Trials (DCTs) Revenue by Company (2020-2025) & (US$ Million)
 Table 36. China Decentralized Clinical Trials (DCTs) Revenue Market Share by Company (2020-2025)
 Table 37. China Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025) & (US$ Million)
 Table 38. China Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025) & (US$ Million)
 Table 39. Japan Decentralized Clinical Trials (DCTs) Revenue by Company (2020-2025) & (US$ Million)
 Table 40. Japan Decentralized Clinical Trials (DCTs) Revenue Market Share by Company (2020-2025)
 Table 41. Japan Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025) & (US$ Million)
 Table 42. Japan Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025) & (US$ Million)
 Table 43. Medidata Company Details
 Table 44. Medidata Business Overview
 Table 45. Medidata Decentralized Clinical Trials (DCTs) Product
 Table 46. Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 47. Medidata Recent Development
 Table 48. IQVIA Company Details
 Table 49. IQVIA Business Overview
 Table 50. IQVIA Decentralized Clinical Trials (DCTs) Product
 Table 51. IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 52. IQVIA Recent Development
 Table 53. Labcorp Company Details
 Table 54. Labcorp Business Overview
 Table 55. Labcorp Decentralized Clinical Trials (DCTs) Product
 Table 56. Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 57. Labcorp Recent Development
 Table 58. PRA Health Sciences Company Details
 Table 59. PRA Health Sciences Business Overview
 Table 60. PRA Health Sciences Decentralized Clinical Trials (DCTs) Product
 Table 61. PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 62. PRA Health Sciences Recent Development
 Table 63. Parexel Company Details
 Table 64. Parexel Business Overview
 Table 65. Parexel Decentralized Clinical Trials (DCTs) Product
 Table 66. Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 67. Parexel Recent Development
 Table 68. ICON Company Details
 Table 69. ICON Business Overview
 Table 70. ICON Decentralized Clinical Trials (DCTs) Product
 Table 71. ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 72. ICON Recent Development
 Table 73. Oracle Company Details
 Table 74. Oracle Business Overview
 Table 75. Oracle Decentralized Clinical Trials (DCTs) Product
 Table 76. Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 77. Oracle Recent Development
 Table 78. CRF Health Company Details
 Table 79. CRF Health Business Overview
 Table 80. CRF Health Decentralized Clinical Trials (DCTs) Product
 Table 81. CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 82. CRF Health Recent Development
 Table 83. Clinical Ink Company Details
 Table 84. Clinical Ink Business Overview
 Table 85. Clinical Ink Decentralized Clinical Trials (DCTs) Product
 Table 86. Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 87. Clinical Ink Recent Development
 Table 88. Medable Company Details
 Table 89. Medable Business Overview
 Table 90. Medable Decentralized Clinical Trials (DCTs) Product
 Table 91. Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 92. Medable Recent Development
 Table 93. Science 37 Company Details
 Table 94. Science 37 Business Overview
 Table 95. Science 37 Decentralized Clinical Trials (DCTs) Product
 Table 96. Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
 Table 97. Science 37 Recent Development
 Table 98. Decentralized Clinical Trials (DCTs) Market Trends
 Table 99. Decentralized Clinical Trials (DCTs) Market Drivers
 Table 100. Decentralized Clinical Trials (DCTs) Market Challenges
 Table 101. Decentralized Clinical Trials (DCTs) Market Restraints
 Table 102. Research Programs/Design for This Report
 Table 103. Key Data Information from Secondary Sources
 Table 104. Key Data Information from Primary Sources


List of Figures
 Figure 1. Decentralized Clinical Trials (DCTs) Product Picture
 Figure 2. Global Decentralized Clinical Trials (DCTs) Market Share by Type: 2024 VS 2031
 Figure 3. Interventional Features
 Figure 4. Observational Features
 Figure 5. Expanded Access Features
 Figure 6. Global Decentralized Clinical Trials (DCTs) Market Share by Application: 2024 VS 2031
 Figure 7. Oncology
 Figure 8. Cardiovascular
 Figure 9. Others
 Figure 10. Decentralized Clinical Trials (DCTs) Report Years Considered
 Figure 11. Global Decentralized Clinical Trials (DCTs) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Decentralized Clinical Trials (DCTs) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Region: 2020 VS 2024
 Figure 14. North America Decentralized Clinical Trials (DCTs) Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 15. Europe Decentralized Clinical Trials (DCTs) Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 16. China Decentralized Clinical Trials (DCTs) Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 17. Japan Decentralized Clinical Trials (DCTs) Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 18. Global Decentralized Clinical Trials (DCTs) Market Share by Players in 2024
 Figure 19. Global Top Decentralized Clinical Trials (DCTs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trials (DCTs) as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Decentralized Clinical Trials (DCTs) Revenue in 2024
 Figure 21. North America Decentralized Clinical Trials (DCTs) Market Share by Type (2020-2025)
 Figure 22. North America Decentralized Clinical Trials (DCTs) Market Share by Application (2020-2025)
 Figure 23. Europe Decentralized Clinical Trials (DCTs) Market Share by Type (2020-2025)
 Figure 24. Europe Decentralized Clinical Trials (DCTs) Market Share by Application (2020-2025)
 Figure 25. China Decentralized Clinical Trials (DCTs) Market Share by Type (2020-2025)
 Figure 26. China Decentralized Clinical Trials (DCTs) Market Share by Application (2020-2025)
 Figure 27. Japan Decentralized Clinical Trials (DCTs) Market Share by Type (2020-2025)
 Figure 28. Japan Decentralized Clinical Trials (DCTs) Market Share by Application (2020-2025)
 Figure 29. Medidata Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 30. IQVIA Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 31. Labcorp Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 32. PRA Health Sciences Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 33. Parexel Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 34. ICON Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 35. Oracle Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 36. CRF Health Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 37. Clinical Ink Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 38. Medable Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 39. Science 37 Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
 Figure 40. Bottom-up and Top-down Approaches for This Report
 Figure 41. Data Triangulation
 Figure 42. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture